The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2012-13 Best Children's Hospitals rankings.
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Experts at the University of Michigan Comprehensive Diabetes Center are available to discuss the impact of diet on diabetes following the announcement this week that Southern chef Paula Deen has type 2 diabetes.
Reporters, producers and editors, here is our holiday gift to you: Story ideas that relate to the holidays, and some evergreen ideas that can help you fill the newspaper or broadcast during the slow news month ahead.
Liver transplantation candidates want to be involved in decisions regarding quality of the donor organ, and many are reluctant to accept organs with a higher risk of failure, according to research by U-M physicians and experts.
The National Institutes of Health is supporting a new effort to understand the complications of diabetes. The University of Michigan will look at the cellular changes that contribute to vision loss, kidney failure and nerve damage in type 1 diabetics.
Waist circumference, a measure of belly fat, is not a better predictor than body mass index for identifying children with an increased risk of developing type 2 diabetes, according to a study by University of Michigan researchers.
The University of Michigan's C.S. Mott Children's Hospital has earned the highest rankings in the state of Michigan and is among the best in the country in pediatric specialties according to the U.S. News Media Group's Best Children's Hospital rankings.
Listen to Dr. Pinsky as he discusses how to live a heart-healthy life.
A rebound of the Hepatitis B virus is common in patients receiving nucleoside analogs for chronic hepatitis but nearly 40% of the rebounds or virological breakthroughs (VBTs) were not related to antiviral drug resistance.
Millions of people in the United States suffer from irritable bowel syndrome, but new research indicates a drug therapy could offer long-lasting relief. William Chey, M.D., professor in the Department of Internal Medicine was among the researchers who studied the drug rifaximin's effects on IBS patients. The research will be published in the New England Journal of Medicine Jan. 6.